Who are it's competitors? Will it be another Biota who's product was not preferred bc the market liked tamiflu better.
On a positive note there is a big dividend coming up and this time it will be franked.
Offshore investors like oz biotech stocks that hAve made it . That is reached all milestones. So a definite long term take over prospect.
Not linked to economic conditions as such. That is when people need the product they will get it bc of illness . So it's shielded away from market volatility.
Trader chart is nice.
So it is investment grade.
I have been averaging up
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $6.116M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.5¢ | $1.154K | 76.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 387316 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 388346 | 2 |
View Market Depth
| Last trade - 10.59am 26/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |